FDA Plans Hearing on Biosimilar Competition, Development

FDA Plans Hearing on Biosimilar Competition, Development

Source: 
RAPS.org
snippet: 

One week after releasing its 11-part biosimilar action plan, the US Food and Drug Administration (FDA) announced it will hold a public hearing to gather input on how it can facilitate the development of biosimilars and ensure they enter the market in a timely fashion.